Interní Med. 2012; 14(10): 350-356

Differential diagnosis and therapy of chronic obstructive pulmonary disease and asthma

prof.MUDr.Vladimír Vondra, DrSc., MUDr.Iveta Vondrová
Plicní a alergologické oddělení Zdravotnického zařízení Praha 5

Chronic obstructive pulmonary disease (COPD) and asthma have several different but also similar characteristics in diagnosis and therapy.

There are different etiologic factors they play the main role (in COPD mostly inhaled harmful irritants, in asthma allergic triggers. The

most important parameter of differences between COPD and asthma are lung function results of bronchial obstruction and its reversibility.

Both diseases are generally under diagnosed and some mistakes are frequent. Correct diagnoses have important influence on

early and optimal therapy according the stage of COPD, and control and severity of asthma. Indacaterol (Onbrez Breezhaler) and roflumilast

(Daxas) were introduced in the year 2011 into the therapy of COPD in the Czech Republic. New modern effective and expensive

treatment of asthma with antibody against IgE (Omalizumab-Xolair) has special indication.

Keywords: chronic obstructive pulmonary disease (COPD), asthma, differential diagnosis, therapy

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vondra V, Vondrová I. Differential diagnosis and therapy of chronic obstructive pulmonary disease and asthma. Interní Med. 2012;14(10):350-356.
Download citation

References

  1. Price DB, Yawn BP, Jones RCM. Jak zlepšit diferenciální diagnostiku CHOPN v primární péči. Medicína po promoci 2011; 12: 6-13.
  2. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of COPD: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. Go to original source... Go to PubMed...
  3. Celli BR, McNee W. Standards for the diagnosis and treatment of COPD: a summary of ATS/ERS position paper. Eur Respir J 2004; 23: 932-946. Go to original source... Go to PubMed...
  4. Musil J, Salajka F, Kos F. Doporučený postup pro diagnostiku a léčbu chronické obstrukční plicní nemoci (CHOPN) - stabilní fáze. Vltavín, Praha 2010: s. 11.
  5. Salajka F, Kašák V, Krčmová I, Konstanský S. Astma bronchiale. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Spol. všeob. lék. Praha 10, novelizace 2008: 11 s.
  6. GINA: updated 2009, www.ginasthma.org. Accesed September 15, 2010.
  7. Kratěnová J. Nová epidemiologická data o alergii, astmatu a alergické rýmě. Alergie 2008; (Suppl 1): 45-48.
  8. Suissa S, Barnes PJ. Inhaled corticosteroid in COPD: the case against. Eur Respir J 2009; 34: 13-16. Go to original source... Go to PubMed...
  9. Mascarenhas J, Azevedo A, Bettencourt P. Coexisting COPD and heart failure: implications for treatment, course and mortality. Curr Opin Pulm Med 2010; 16: 106-111. Go to original source... Go to PubMed...
  10. Marsh SE, Travers J, Weatherall M, et al. Proportional classification of COPD phenotypes. Thorax 2008; 63: 761-767. Go to original source... Go to PubMed...
  11. Teřl M. Diagnostický přístup k astmatu prizmatem eozinofilie a alergie. Stud Pneumol Phtiseol 2009; 69: 130-139.
  12. Sedlák V, Koblížek V. Určování fenotypu astmatu ve výzkumu a klinické praxi. Med po Prom 2009; srpen, spec. vyd., s. 1-12.
  13. Buist AS. International variation in the prevalence of COPD (The BOLD study). Lancet 2007; 370: 741-760. Go to original source... Go to PubMed...
  14. Gibson PG, Simpson JL. The overlap syndrom of asthma and COPD: what are its feature and how important is it? Thorax 2009; 64: 728-735. Go to original source... Go to PubMed...
  15. Menezes AM, Perez-Padilla R, Jardim JR, et al. COPD in five Latin America cities. Lancet 2005; 366: 875-1881. Go to original source...
  16. Dold D, Wjst M, von Mutius E, et al. Genetic risk for asthma, allergic rhinitis and atopic dermatitis. Arch Dis Child 1992; 67: 1018-1022. Go to original source... Go to PubMed...
  17. Seberová E. Alergická rýma. Praha: Maxdorf 2006: 112 s.
  18. Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43: 75-80. Go to original source... Go to PubMed...
  19. Jones RC, Dickson-Spillman M, Mather MJ, et al. Accuracy of diagnostic registers and management of COPD: the Devon primary care unit. Respir Res 2008; 9: 62. Go to original source... Go to PubMed...
  20. Kolektiv autorů. Diagnostika, léčba a prevence průduškového astmatu v České republice. Vyd. ČIPA, Praha, 2008: 120 s.
  21. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration 2006; 73: 296-305. Go to original source... Go to PubMed...
  22. Pohunek P, Svobodová T. Průduškové astma v dětském věku. Praha: Maxdorf 2007: 112 s.
  23. Kašák V. Asthma bronchiale. Praha: Maxdorf 2005; 148 s.
  24. Kašák V. Chronická obstrukční plicní nemoc. Praha: Maxdorf 2006: 187 s.
  25. Koblížek V, Paráková Z, Antušová Z. Časná stadia CHOPN - cesta ke spolehlivé diagnostice a efektivní terapii (souhrn pro praxi). Remedia, Pneumologie IV 13. 6. 2011, U114-V119.
  26. Calverley PMA, Rabe K, Fabbri LM, et al. Roflumilast in symptomatic COPD: two randomised clinical trials. Lancet 2009; 374: 685-694. Go to original source... Go to PubMed...
  27. Fabbri LM, Calverley PMA, Izquierdo A, et al. Roflumilast in moderate-to-severe COPD treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009; 374: 695-703. Go to original source... Go to PubMed...
  28. Cazzola M, Calzetta L, Matera MG. Beta2 - adrenoceptor agonists, current and future direction. Brit J Pharmacol 2011; 163: 4-17. Go to original source... Go to PubMed...
  29. Gross NJ. The COPD Pipeline IV. J Chron Obstr Dis 2010; 7: 229-231. Go to original source... Go to PubMed...
  30. Sedlák V, Chlumský J, Teřl M, et al. Doporučený postup diagnostiky a léčby obtížně léčitelného bronchiálního astmatu NTCA 2009 - www.pneumologie.cz.
  31. Novák J. Léčba astmatu inhalačními kortikosteroidy - 2011. Med pro praxi 2011; 8: 2-7.
  32. Koblížek V, Sedlák K, Paráková Z, et al. Obtížně léčitelné astma (OLA) - přístup k pacientovi s těžkým astmatem. Alergie 2008; 10: 6(Suppl 1/2006): 46-48.
  33. Pohunek P. Biologická léčba těžkého astmatu u dětí monoklonální anti-IgE protilátkou omalizumabem. Farmakoterapie 2010; 6: 364-368.
  34. Kašák V. Astma - pověry, mýty, fakta v roce 2011. Alergie 2012; 14: 94-100.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.